GlobeNewswire

Paysafe unveils exciting new global brand identity

Dela

New "Plug into Paysafe" brand positioning reinforces Paysafe as the platform of choice in global payments

LONDON, June 04, 2018 (GLOBE NEWSWIRE) -- Leading global payments provider, Paysafe, has unveiled an exciting and thought provoking new-look logo and brand identity coupled with a compelling new  Plug into Paysafe  global brand positioning.

As part of its increased marketing investment, which reinforces Paysafe as the 'New Big' in global payments, the payments provider has also overhauled its website to better showcase its unrivalled global payments portfolio to businesses. 

The new logo and brand identity were simultaneously showcased at two recent high-profile, televised sports events. Firstly, in the U.S., as part of Paysafe's sponsorship of the 2018 Verizon IndyCar series, the newly-branded number 19 Paysafe car took to the tracks at the hugely popular Indy500 race in front of millions of viewers. In the UK, the new Paysafe logo was also showcased on the shirts of the mighty Barbarians, one of the most celebrated teams in world rugby, at the England vs Barbarians match held at the Twickenham Stadium, London. The Paysafe-backed Barbarians won.

The  Plug into Paysafe  positioning, the core theme of Paysafe's new, global marketing narrative, emphasises how businesses can 'plug' into Paysafe's unique and diverse platform of proprietary payment capabilities covering every aspect of the payments ecosystem. Payment products include cash solutions, pre-paid cards, mobile order ahead, credit options, digital wallets and point of sale technology. Paysafe also offers, and continues to invest in growing, extensive payment processing and acquiring capabilities; only last month it announced its acquisition of iPayment Holdings, a leading payments processor in the U.S. This latest acquisition confirms Paysafe as a top 5 non-bank payment processor in the country and the payment partner of choice for the fast-growing SMB sector. 

According to Paysafe Group Chief Marketing Officer, Oscar Nieboer, who is spearheading the new marketing approach, the updated brand identity and messaging aims to articulate how Paysafe offers flexibility and scalability so that businesses can create a highly customer-centric payments experience that meets their individual needs yet give them the reach of a global footprint.

Nieboer explains how this thinking was behind the new brand design: "Our new brand incorporates the colon to reflect that we provide a connection to an open-ended network of leading solutions and capabilities. The new identity represents the multiple elements of Paysafe's network that can be organised in many ways to create highly relevant, tailored payment capabilities."

The new brand positioning is being immediately brought to life with today's global launch of Paysafe's ground-breaking new online cash solution - Paysafecash - which enables consumers to use cash for online shopping instead of entering bank account or credit card details online. Significantly, it's the first online cash solution that can be used to upload funds into digital wallets, including Paysafe's own popular digital wallets, Skrill and NETELLER. 

The new brand positioning will also see Paysafe's payment by invoice and instalment solution, change its brand from Payolution to Paysafe: Pay Later. The company is set to expand the service, which is already well established in the DACH region, into new markets including the Canada, the U.K. and the U.S.

With over 20 years of online payment experience, a combined transactional volume of US $56 billion in 2017 and over 2,600 staff located in 12 global locations, Paysafe connects businesses and consumers across 200 payment types in over 40 currencies. The company combines the scale of an established global brand with the entrepreneurial and responsive spirit of a start-up.

Nieboer concluded: "As a company, we have grown rapidly through both acquisition and organic growth, and because of that we offer customers access to an unrivalled range of proprietary payment products and capabilities, along with developer tools, all in one place. Our new brand identity and the Plug into Paysafe positioning very much reinforce how we're evolving and growing as a highly disruptive, customer-centric company. These are exciting times."

NOTES TO EDITORS

  • To hear Oscar Nieboer, Paysafe's Chief Marketing Officer, provide an overview of the rebrand click here.
  • Paysafecash is being demonstrated this week at the Paysafe stand at Money 2020 Europe (E70), taking place in Amsterdam on June 4 - 6, 2018.
  • Paysafe's capabilities include: the market-leading digital wallet brands Skrill® and NETELLER®; paysafecard®, a worldwide market-leader in prepaid payment methods for the internet and its new Paysafecash service; Income Access, a marketing and technology company primarily operating in the affiliate space; GOLO, a mobile ordering platform; and, as part of its Paysafe for Business offer, processing, acquiring and card solutions services and its Pay Later invoice and instalment offering.
  • To see a video of the new Paysafe brand unveiling on the IndyCar series car, click here.
  • Source: World Bank Report, 2015.

About Paysafe

Paysafe is a leading global provider of end-to-end payment solutions. Its core purpose is to enable businesses and consumers to connect and transact seamlessly through industry-leading capabilities in payment processing, digital wallet and online cash solutions. Delivered through an integrated platform, Paysafe solutions are geared toward mobile-initiated transactions, real-time analytics and the convergence between brick-and-mortar and online payments. With over 20 years of online payment experience, a combined transactional volume of US $56 billion in 2017 and over 2,600 staff located in 12 global locations. Paysafe connects businesses and consumers across 200 payment types in over 40 currencies around the world. For more information, visit www.paysafe.com.

For Media Inquiries:

Kate Aldridge: Vice President, Corporate Communications, Paysafe Group

Office: +44(0)203 934 9197 or Mobile +44(0)750 079 7547

E-Mail: Kate.Aldridge@paysafe.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Paysafe Group via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Immunicum AB (publ) Announces Upcoming Investor Events in October and November22.10.2018 16:00Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Announces Upcoming Investor Events in October and November Immunicum AB (publ; IMMU.ST) announced today that the Company will participate in and host investor events in October and November. At all events Carlos de Sousa, CEO of Immunicum, and other members of the management team, will provide a corporate presentation and be available for a question and answer session. BioStock Life Science Summit Date: October 25, 2018 Presentation Time: 18.50 Central European Time Venue: Medicon Village, Scheelevägen 2, Building 302-auditorium, Lund, Sweden Registration Link: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicum Investor Event - Gothenburg Date: October 29, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venue: First Hotel G, Nils Ericsonplatsen, 411 03 Gothenburg, Sweden Immunicum Investor Event - Stockholm Date: October 30, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venu

Immunicum AB (publ) meddelar kommande investerarevent under oktober och november22.10.2018 16:00Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) meddelar kommande investerarevent under oktober och november Immunicum AB (publ; IMMU.ST) meddelar i dag att bolaget kommer att anordna och delta i investerarträffar under oktober och november. Vid samtliga event kommer Carlos de Sousa, Immunicums VD, och övriga medlemmar av ledningsgruppen, att hålla en presentation av bolaget och vara tillgängliga för att svara på frågor. BioStock Life Science Summit Datum: 25 oktober 2018 Presentationstid: Kl. 18.50 CET Plats: Medicon Village, Scheelevägen 2, byggnad 302 - hörsalen, Lund Länk för registrering: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicums investerarevent - Göteborg Datum: 29 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: First Hotel G, Nils Ericsonplatsen, 411 03, Göteborg Immunicums investerarevent - Stockholm Datum: 30 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: Ingenjörshuset Citykonferensen, Plan 1, Malmski

Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress22.10.2018 12:45Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress -- Intratumoral behandling med ilixadencel, en cellbaserad, lagringsbar immunaktiverare, ger en synergistisk antitumöreffekt och förstärker effekten av behandling med anti-PD-1 och anti-CD137 i djurmodeller -- Immunicum AB (publ; IMMU.ST) presenterar under 2018 års ESMO kongress (European Society for Medical Oncology) prekliniska resultat som visar en synergistisk anti-tumöreffekt när bolagets ledande produkt ilixadencel ges i kombination med en checkpointhämmare eller immunaktiverare. Resultaten från studien, som presenteras på en poster, visar att intratumoralt administrerat ilixadencel kan förstärka anti-tumörsvar och överlevnad vid behandling med checkpointhämmare eller immunaktiverare. Detta visar på potentialen hos ilixadencel att bli en komplementerande verkningsmekanism till flera olika framtida im

Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 201822.10.2018 12:45Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018 -- Intratumoral treatment with ilixadencel, an off-the-shelf cell-based immune primer, provides synergistic anti-tumor effect and enhances efficacy of anti-PD-1 and anti-CD137 treatment in animal model -- Immunicum AB (publ; IMMU.ST) announced today the presentation of preclinical results that showed anti-tumor synergy between its lead product ilixadencel and a checkpoint inhibitor or an immune enhancer in a poster at the European Society for Medical Oncology (ESMO) 2018 Congress. The results of the study highlight the ability of intratumoral ilixadencel to enhance anti-tumor response and survival of systemic checkpoint inhibitors (anti-PD-1) or immune enhancers (anti-CD137/4-1BB). This emphasizes the potential for ilixadencel in multiple future immuno-oncology combination strategies by incorporating complementary mech

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum